There has never been a better time to be in the musculoskeletal industry and the outlook for the next 12-15 years is quite optimistic. Path4 understands this industry. The principals will use their passion, strong experience and industry connections to seek out, invest in and incubate technologies for commercialization.

Industry analyst, Robin Young, with Health Point Research says:

"We believe orthopedics will emerge as the single most promising source of future investor returns in healthcare, given the confluence of demographics, technology and global expansion.

While other healthcare categories such as cardiovascular devices, cancer or biotech may have been more lucrative in the past, what the American Association of Orthopedic Surgeons (AAOS) calls the "Decade of Orthopedics" provides the best opportunity for future investor profits in healthcare".